Orris

Aquavorin

Reading File
Searching the Web

aquaporin water channels structure function physiology 2025

Finding Sources
Searching PubMed

aquaporin water channel physiology disease

Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
Loading Image
I now have comprehensive information from multiple authoritative sources. Here is the full answer:

Aquaporins (AQPs) - Water Channel Proteins

Overview

Aquaporins are a family of small (~30 kDa) integral membrane proteins that function as selective water channels, enabling rapid water diffusion across cell membranes. The first aquaporin (AQP1) was identified in 1991 by Peter Agre, work for which he was awarded the Nobel Prize in Chemistry (2003). To date, 13 mammalian aquaporins (AQP0-AQP12) have been cloned, expressed in virtually every tissue involved in fluid transport.

Molecular Structure

The diagram from Goodman & Gilman's illustrates the architecture:
Aquaporin structure - 6 transmembrane domains folding to form a tetramer with NPA water pore
  • Each monomer has 6 transmembrane (TM) helical domains with intracellular N- and C-termini
  • Loops b and e each contain the signature asparagine-proline-alanine (NPA) motif - these loops dip into the membrane and their two NPA sequences align to form the actual water pore
  • TM domains 1, 2, and 6 cluster together; domains 3, 4, and 5 juxtapose on the other side
  • Four monomers assemble into a tetramer in the membrane, though each monomer functions as its own independent water pore
  • The pore geometry excludes protons (H⁺) and ions - water molecules pass in single file, and their orientation at the NPA region prevents proton conductance (the "Grotthuss mechanism" is blocked)

Classification

ClassMembersPermeability
Strict aquaporinsAQP0, AQP1, AQP2, AQP4, AQP5, AQP6Water only
AquaglyceroporinsAQP3, AQP7, AQP8, AQP9Water + glycerol (+ larger solutes for AQP9)
Dual water/ion channelsAQP0, AQP1, AQP6Water + ions (controversial/context-dependent)

Renal Aquaporins - The Key Four

At least seven aquaporins are expressed in distinct kidney segments. The four most physiologically important are:

AQP1

  • Location: Apical and basolateral membranes of proximal tubule; thin descending limbs of long-loop nephrons; descending vasa recta
  • Function: Allows water to follow the osmotic gradient set up by active solute transport in the proximal tubule, keeping tubular fluid isosmotic. Responsible for ~60-70% of filtered water reabsorption
  • Knockout phenotype: AQP1-null mice show 80% reduction in proximal tubular water permeability, severe polyuria, and inability to concentrate urine even after water deprivation - confirming AQP1 is essential for the countercurrent multiplication mechanism

AQP2

  • Location: Exclusively in principal cells of the connecting tubule and collecting duct (apical plasma membrane + intracellular vesicles)
  • Function: The vasopressin-regulated water channel - the master switch for urine concentration
  • Regulation by vasopressin (AVP):
    1. AVP binds V2 receptor → adenylyl cyclase activation → ↑cAMP → PKA activation
    2. PKA phosphorylates AQP2 at Ser256 - this is the critical phosphorylation site
    3. AQP2-containing vesicles traffic to and fuse with the apical plasma membrane (exocytosis)
    4. Water permeability increases dramatically; water is reabsorbed from the tubule lumen
    5. On AVP withdrawal, AQP2 is internalized by clathrin-mediated endocytosis and recycled back to subapical vesicles
    • Chronic dehydration/AVP stimulation also upregulates AQP2 mRNA and protein expression via cAMP
The fluorescence and electron microscopy images below directly demonstrate AQP2 trafficking:
AQP2 redistribution from cytoplasmic vesicles to apical membrane after vasopressin treatment, shown by immunofluorescence and immunogold EM
  • Left (Control/Pre-AVP): AQP2 (green) is scattered in intracellular vesicles. Gold particles are on cytoplasmic vesicles with only a few at the apical membrane
  • Right (+ Vasopressin/AVP): AQP2 accumulates at the apical plasma membrane (arrows); cytoplasmic vesicle labeling decreases dramatically

AQP3 and AQP4

  • Location: Basolateral membranes of collecting duct principal cells (exit pathways for water reabsorbed apically by AQP2)
  • AQP3 dominates in the cortical collecting duct; AQP4 in the inner medullary collecting duct
  • AQP3 knockout mice: >10-fold increase in urine volume (polyuria), markedly reduced urinary osmolality
  • AQP4 knockout mice: Only modestly reduced maximal urine concentrating ability (reduced AQP4 inner medullary permeability is partially compensated because most osmotic reabsorption occurs in the cortex where AQP3 is dominant)

Other Notable Aquaporins

AQPKey LocationClinical / Physiological Relevance
AQP0 (MIP)Lens fiber cellsCataract formation when mutated
AQP4Brain astrocyte endfeet, spinal cordTarget of autoantibodies in neuromyelitis optica spectrum disorder (NMOSD)
AQP5Salivary/lacrimal/sweat glands, type I alveolar cellsSaliva and tear production
AQP7Adipocytes, proximal tubule apical brush borderGlycerol release from fat; glucose metabolism
AQP9HepatocytesGlycerol uptake for gluconeogenesis

Pharmacological Regulation

From Goodman & Gilman's:
  • NSAIDs (e.g., indomethacin): Enhance antidiuretic response to vasopressin by inhibiting prostaglandin synthesis (PGs attenuate vasopressin's effect; NSAIDs remove this brake)
  • Carbamazepine, chlorpropamide: Enhance vasopressin's antidiuretic effects (mechanism incompletely understood)
  • Lithium: Inhibits V2 receptor-mediated adenylyl cyclase stimulation → reduces AQP2 trafficking → causes nephrogenic diabetes insipidus (NDI)
  • Demeclocycline: Attenuates antidiuretic effects of vasopressin by reducing cAMP accumulation; used historically to treat SIADH
  • AVP-induced cAMP-PKA activation also directly upregulates AQP2 mRNA/protein expression with chronic stimulation

Clinical Diseases

DiseaseAQP InvolvedMechanism
Nephrogenic diabetes insipidus (NDI)AQP2Loss-of-function mutations in AQP2, or V2R mutations; also acquired (lithium, demeclocycline)
Central diabetes insipidusAQP2Absent AVP → no AQP2 membrane insertion
Neuromyelitis optica (NMOSD)AQP4IgG autoantibodies target AQP4 on astrocytic endfeet → complement-mediated destruction of spinal cord/optic nerve
CataractAQP0Mutations in the lens major intrinsic protein
Brain edemaAQP4AQP4 facilitates cytotoxic edema; AQP4 deletion reduces edema in some models
Glymphatic dysfunctionAQP4AQP4 on astrocyte endfeet drives perivascular CSF-interstitial fluid exchange; linked to Alzheimer's disease pathology (Keil et al., Science 2025)
Sources:
This is a shared conversation. Sign in to Orris to start your own chat.